CASH, CASH EQUIVALENTS, AND MARKETABLE SECURITIES (Details 2) (USD $)	3 Months Ended	9 Months Ended			1 Months Ended		1 Months Ended
	Sep. 30, 2012	Sep. 30, 2012	Sep. 30, 2012 Series A preferred stock	Sep. 30, 2012 Maximum	Jul. 31, 2012 AVI	Dec. 31, 2011 AVI	Sep. 30, 2012 Sarepta
Cash, cash equivalents, and marketable securities
Number of shares held						2,384,211
Reverse stock split					6
Proceeds from shares sold after payment of broker commissions							$ 5,384,000
Gain on sale after broker commissions							2,606,000
Other than temporary decline in value of investments	485,000	524,000
Price per share (in dollars per share)	$ 2.20	$ 2.20
Total investment	1,500,000	1,500,000
Disposition of fixed assets and other intellectual property of Utah laboratory location	924,000
Gain on disposition of assets	$ 576,000
Cost method investment
Cost Method Investment Number of Shares Acquired			681,632
Percentage of ownership interest				20.00%